logo
logo

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities

Oct 02, 202410 months ago

Contract Type

partnership

IrvineBiotechnology

Description

Oncocyte Corporation has entered into a securities purchase agreement with new and existing investors, including Bio-Rad Laboratories, Inc. The company expects to receive approximately $10.2 million from the private placement, which will be used for working capital and general corporate purposes. This partnership demonstrates strong support from both current and new shareholders, including their corporate partner, Bio-Rad Laboratories, Inc.

Company Information

Company

OncoCyte Corp

Location

15 CUSHING

Irvine, California, United States

About

Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Related People